Skip to search formSkip to main contentSkip to account menu

fasudil

Known as: 1-(5-Isoquinolinesulfonyl)homopiperazine, 1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)-, Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVE The aim of this study was to study the impacts of Rho kinase inhibitor Fasudil on expressions of Rho/ROCK signaling… 
2010
2010
Objective To investigate the effects of fasudil on the expressions of Bcl-2,Bax and the hemodynamics in myocardium of rats with… 
2009
2009
MG-CoA reductase inhibitors (statins) are potent cholesterol-lowering drugs widely used in clinical practice for primary and… 
2009
2009
Aim To study the pharmacokinetics of Fasudil. Design and Method The HPLC methods with UV detection were used for measurement of… 
2008
2008
Objective To observe the effects of fasudil on hemorheology in patients with acute ischemic stroke.Methods Eighty-five patients… 
2008
2008
Pathophysiological mechanisms underlying vasospasm are diverse and not yet fully elucidated. However, it has recently been shown… 
2007
2007
各種脳血管障害治療の医療経済分析は本邦では十分なされていない. 今回我々は脳梗塞急性期治療薬として効果が示された塩酸ファスジル (以下ファスジル) を, 70… 
2005
2005
Jih-Lie Tseng, Gary D. Deng, Sabine Schirm, Anthony Johns, Katalin Kauser, William P. Dole Feng, Meredith Halks-Miller, Mithra… 
2002
2002
Objective:To investigate the effects of a new agent fasudil on delayed cerebral vasospasm after subarachniod hemorrhage Methods…